PTU-159 Characterisation of Oesophageal Muc1 Expression in the Progression to Oesophageal Adenocarcinoma

Gut - United Kingdom
doi 10.1136/gutjnl-2013-304907.249
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

GATA6 Expression in Barrett's Oesophagus and Oesophageal Adenocarcinoma

Digestive and Liver Disease
HepatologyGastroenterology
2015English

Neoadjuvant Chemotherapy in Oesophageal Adenocarcinoma

The Lancet Oncology
Oncology
2017English

New Developments in Oesophageal Adenocarcinoma Treatment

European Oncology and Haematology
OncologyHematology
2008English

Neoadjuvant Chemotherapy in Oesophageal Adenocarcinoma – Authors' Reply

The Lancet Oncology
Oncology
2017English

Epigenetic Biomarkers in Progression From Non-Dysplastic Barrett's Oesophagus to Oesophageal Adenocarcinoma: A Systematic Review Protocol

BMJ Open
Medicine
2016English

Fibroblasts Derived From Oesophageal Adenocarcinoma Differ in DNA Methylation Profile From Normal Oesophageal Fibroblasts

Scientific Reports
Multidisciplinary
2017English

Repurposing of KLF5 Activates a Cell Cycle Signature During the Progression From Barrett's Oesophagus to Oesophageal Adenocarcinoma.

2020English

Met Expression Is an Independent Prognostic Risk Factor in Patients With Oesophageal Adenocarcinoma

British Journal of Cancer
Cancer ResearchOncology
2008English

PTU-188 “Knitted” Oesophageal Stents: Superior Conformability With No Trade Off: Abstract PTU-188 Figure 1

Gut
Gastroenterology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy